Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Zeitschrift Fur Rheumatologie
|
February 20, 1999
Spinal factors in the generation of fibromyalgia syndrome
W Müller, J Kelemen, T Stratz
Zeitschrift Fur Rheumatologie
|
February 2, 2006
[5-HT3 receptor antagonist als analgetics in rheumatic diseases]
W Müller, B L Fiebich, T Stratz
Rheumatology International
|
July 27, 2007
The classification of fibromyalgia syndrome
W Müller, E M Schneider, T Stratz
Scandinavian Journal of Rheumatology. Supplement
|
November 2, 2004
Influence of tropisetron on the serum substance P levels in fibromyalgia patients
T Stratz, B Fiebich, U Haus, et al.
Scandinavian Journal of Rheumatology. Supplement
|
November 2, 2004
Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone
W Samborski, T Stratz, S Mackiewicz, et al.
The Journal of Rheumatology
|
August 1, 1996
Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study
P Hrycaj, T Stratz, P Mennet, et al.
Zeitschrift Fur Rheumatologie
|
January 1, 1991
[Blocking of S2 receptors--a new treatment principle in generalized tendomyopathy (fibromyalgia)?]
T Stratz, P Mennet, H P Benn, et al.
Clinical Rheumatology
|
July 1, 1995
Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis
P Hrycaj, T Stratz, C Kovac, et al.
Scandinavian Journal of Rheumatology. Supplement
|
November 2, 2004
Treatment of fibromyalgia with tropisetron--dose and efficacy correlations
M Späth, T Stratz, L Färber, et al.
Zeitschrift Fur Rheumatologie
|
May 1, 1996
[Biochemical changes in fibromyalgia]
W Samborski, T Stratz, T Schochat, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Zeitschrift Fur Rheumatologie
|
February 20, 1999
Spinal factors in the generation of fibromyalgia syndrome
W Müller, J Kelemen, T Stratz
Zeitschrift Fur Rheumatologie
|
February 2, 2006
[5-HT3 receptor antagonist als analgetics in rheumatic diseases]
W Müller, B L Fiebich, T Stratz
Rheumatology International
|
July 27, 2007
The classification of fibromyalgia syndrome
W Müller, E M Schneider, T Stratz
Scandinavian Journal of Rheumatology. Supplement
|
November 2, 2004
Influence of tropisetron on the serum substance P levels in fibromyalgia patients
T Stratz, B Fiebich, U Haus, et al.
Scandinavian Journal of Rheumatology. Supplement
|
November 2, 2004
Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone
W Samborski, T Stratz, S Mackiewicz, et al.
The Journal of Rheumatology
|
August 1, 1996
Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study
P Hrycaj, T Stratz, P Mennet, et al.
Zeitschrift Fur Rheumatologie
|
January 1, 1991
[Blocking of S2 receptors--a new treatment principle in generalized tendomyopathy (fibromyalgia)?]
T Stratz, P Mennet, H P Benn, et al.
Clinical Rheumatology
|
July 1, 1995
Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis
P Hrycaj, T Stratz, C Kovac, et al.
Scandinavian Journal of Rheumatology. Supplement
|
November 2, 2004
Treatment of fibromyalgia with tropisetron--dose and efficacy correlations
M Späth, T Stratz, L Färber, et al.
Zeitschrift Fur Rheumatologie
|
May 1, 1996
[Biochemical changes in fibromyalgia]
W Samborski, T Stratz, T Schochat, et al.
Page
of 5